2m 2m 2m 2m 2m 2m 2m
DIAMEDICA THERAP (DMAC)
NASDAQ
$6.46+$0.57 (+9.75%)
Price as of Jun 23, 2026 7:54 PM EDT- $317.4MMarket Cap
- 61.37%1-Year Change
- BiotechnologyIndustry
DIAMEDICA THERAP (DMAC)
$6.46+$0.57 (+9.75%)
DMAC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.89 | ||
Change | +$0.04 (+0.68%) | ||
Open | $5.85 | ||
High | $6.06 | ||
Low | $5.77 | ||
Previous Close | $5.85 | ||
Volume | 142,628 | ||
30-Day Average Volume | 172,239 | ||
1-Week Change | 4.62% | ||
1-Month Change | -0.34% | ||
1-Year Change | 61.37% | ||
3-Year Change | 45.43% | ||
5-Year Change | -17.04% | ||
Fundamentals | |||
Shares Outstanding | 53.9M | ||
Total Assets | $53.1M | ||
Market Cap | $317.4M | ||
Enterprise Value | $312.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$10.0M | ||
Free Cash Flow | -$9.1M | ||
EBIT | -$10.0M | ||
EBITDA | -$10.0M | ||
Net Working Capital | $46.6M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -31 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -31 | ||
PEG | 2 | ||
Price/Free Cash Flow | -35 | ||
Price/Operating Cash Flow | -35 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue